Advertisement

Topics

Latest "Daiichi Pharmaceutical" News Stories - Page: 5

15:21 EST 13th November 2018 | BioPortfolio

Here are the most relevant search results for "Daiichi Pharmaceutical" found in our extensive news archives from over 250 global news sources.

More Information about Daiichi Pharmaceutical on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Daiichi Pharmaceutical for you to read. Along with our medical data and news we also list Daiichi Pharmaceutical Clinical Trials, which are updated daily. BioPortfolio also has a large database of Daiichi Pharmaceutical Companies for you to search.

Showing "Daiichi Pharmaceutical" News Articles 101–125 of 8,800+

Probably Relevant

Why Consider Investing in Pharmaceutical Stocks?

The pharmaceutical market is expected to increase in value in the coming years, meaning that there are opportunities for investing in pharmaceutical stocks. The post Why Consider Investing in Pharmaceutical Stocks? appeared first on Investing News Network.


Immunic AG: Immunic schließt globalen Options- und Lizenzvertrag mit Daiichi Sankyo ab

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP-Media / 2018-11-05 / 09:00 *Immunic schließt globalen Options- und Lizenzvertr...

Teva Braces For A Bigger Hit As Price Competition Intensifies For Copaxone

Teva has been able to hold onto a roughly 85% share of the Copaxone 40 mg market, but expects pressure...   


Savaysa (Edoxaban; Daiichi Sankyo) Drug Overview 2017/18-2026 - A Direct Oral Factor Xa ...

ResearchAndMarkets.comLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Hematological Drugs Read more...

‘Booming’ pharmaceutical industry in Scotland

A report conducted by the University of Strathclyde has revealed that the pharmaceutical market in Scotland is booming with over £462m in exports... The post ‘Booming’ pharmaceutical industry in Scotland appeared first on European Pharmaceutical Review.

Phase-III-Studie QuANTUM-R belegt, dass Quizartinib von Daiichi Sankyo als Einzelwirkstoff das Gesamtüberleben bei Patienten mit rezidivierter/refraktärer AML mit FLT3-ITD Mutationen im Vergleich zu Chemotherapie verlängert

-- Daten aus QuANTUM-R, vorgestellt als Late-Breaking-Vortrag im Rahmen einer Plenarsitzung anlässlich des 23. Kongresses der European Hematology Association (EHA) -- Quizartinib ist der erste FLT3...

How can predictive analytics help pharmaceutical manufacturing?

Predictive analytics can help pharmaceutical companies with better strategies, communication, and ways to meet the needs of end users... The post How can predictive analytics help pharmaceutical manufacturing? appeared first on European Pharmaceutical Review.

Daiichi Sankyo's FLT3 Inhibitor Quizartinib Receives Orphan Drug Designation from Japanese MHLW for FLT3-Mutated AML

- Orphan drug designation in Japan for quizartinib follows recent Breakthrough Therapy designation received from the U.S. Food and Drug Administration (FDA) - Significant unmet medical need exists...

Daiichi Sankyo Presents First Snapshot Analyses from Global ETNA-AF Programme of Oral, Once-daily LIXIANA? (edoxaban) in Patients with Nonvalvular Atrial Fibrillation in Routine Clinical Practice

MUNICH, Aug. 28, 2018 /PRNewswire/ -- The Global ETNA-AF programme is a large and comprehensive single non-vitamin K oral anticoagulant (NOAC) repository of real-world data, as part of the Edoxaba...

Top Pharmaceutical ETFs

Experienced and novice investors alike may want to consider pharmaceutical ETFs as a way to stay informed about what companies are leading the industry. The post Top Pharmaceutical ETFs appeared first on Investing News Network.

Daiichi Sankyo to Present New Data on Multiple Compounds Including Antibody Drug Conjugates DS-8201 and U3-1402 at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

- Updated results from the large ongoing phase 1 study of DS-8201, an investigational HER2-targeting antibody drug conjugate (ADC), in metastatic breast cancer, gastric cancer and other tumors wit...

Endo International acquires Par Pharmaceutical

Endo International and Par Pharmaceutical Holdings have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. The combination will create a leading specialty pharmaceutical company with a generics business that is one of the industry's fastest growing and more » The post Endo Intern...

Automation could help China’s pharmaceutical manufacturing market

Automation could help China to become a world leader in the pharmaceutical industry, competing with companies from America and Europe... The post Automation could help China’s pharmaceutical manufacturing market appeared first on European Pharmaceutical Review.

Pharmaceutical industry worth £1.7bn to Scottish economy

Scotland’s pharmaceutical sector is worth £1.7bn (gross value added) to the country’s economy, according to a report by the Fraser...Read More... The post Pharmaceutical industry worth £1.7bn to Scottish economy appeared first on Pharmaceutical Technology.

Deals this week: Eisai Pharmaceutical, Abbvie, Otsuka

Eisai Pharmaceutical has signed an agreement with Eurofarma Laboratorios for the marketing and distribution of its anti-obesity drug lorcaserin hydrochloride...Read More... The post Deals this week: Eisai Pharmaceutical, Abbvie, Otsuka appeared first on Pharmaceutical Technology.

Top 25 Global Pharmaceutical Companies by Market Cap 2018

Data FocusHighlights of the Top 25 publicly traded global pharmaceutical companies by Market Cap.Staff Author: 

Phase III Data ENLIVEN Pexidartinib’s Prospects But Liver Tox An Issue?

Phase III results for Daiichi Sankyo’s pexidartinib presented at ASCO provide new hope in a rare tumor type with no...   

5 Pharmaceutical IPOs in July

These companies have recently completed the steps to join the public market, allowing more opportunities for pharmaceutical investors. The post 5 Pharmaceutical IPOs in July appeared first on Investing News Network.

Generic cancer pain relief launched in Japan

Japan-based Daiichi Sankyo announced on 15 June 2018 that it had launched a generic version of cancer pain relief Fentos Tape (fentanyl citrate tape).

JW Pharmaceutical invests in British anti-cancer drugs developer

South Korea-based pharmaceutical products company JW Pharmaceutical has invested $2.6m in British anti-cancer drugs developer Argonaut Therapeutics. This investment gives...Read More... The post JW Pharmaceutical invests in British anti-cancer drugs developer appeared first on Pharmaceutical Technology.

GE provides FlexFactory platform to Xiangxue Pharmaceutical

GE Healthcare has agreed to supply its FlexFactory manufacturing platform to China-based Xiangxue Pharmaceutical for high-affinity and high-specificity T cell...Read More... The post GE provides FlexFactory platform to Xiangxue Pharmaceutical appeared first on Pharmaceutical Technology.

Daiichi Sankyo Presents Updated Results of [Fam-] Trastuzumab Deruxtecan (DS-8201) in Patients with HER2 Expressing Advanced Colorectal Cancer at 2018 European Society for Medical Oncology (ESMO) Congress

- Updated analysis from ongoing phase 1 study of [fam-] trastuzumab deruxtecan (DS-8201) demonstrated a confirmed overall response rate of 15.8 percent and a disease control rate of 84.2 percent i...

Pharmaceutical manufacturing companies in India: ones to watch

Pharmaceutical manufacturing companies in India are one of the world’s largest sources of generic drugs, supplying 50% of global demand...Read More... The post Pharmaceutical manufacturing companies in India: ones to watch appeared first on Pharmaceutical Technology.

Avara Pharmaceutical to buy Novartis’s production plant in Canada

US-based Avara Pharmaceutical Services has signed an asset purchase agreement to acquire Novartis Technical Operations’ sterile manufacturing facility for injectable...Read More... The post Avara Pharmaceutical to buy Novartis’s production plant in Canada appeared first on Pharmaceutical Technology.

FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo's FLT3 Inhibitor Quizartinib for Relapsed/Refractory FLT3-ITD AML

- Quizartinib has received FDA Breakthrough Therapy designation in patients with relapsed/refractory FLT3-ITD AML, a very aggressive form of the disease associated with poor prognosis - Significan...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks